Your region: Rest of World

References

Set Descending Direction

1-25 of 120

Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Products Transfection
Free Sample Offer

Instruction for Use:

In the „Transfection Reagent Selection Guide“ you can find existing references by setting different filters e.g. for your combination of nucleic acid and cell type. Appropriate keywords in the “Search references“ at the top of the page can also yield a result. A reference indicates that the found transfection reagent has been successfully used for the corresponding application. Ideally, tested transfection parameters and transfection efficiencies are specified.

No reference? > General Selection Guide

If the list does not include a reference concerning your cell type, this does not mean that there is no suitable reagent available, but only that there is no report of experiences with this cell type. In this case it is necessary to preselect (General Selection Guide) and test a reagent (Free Sample Offer). If you want to write an application note for us we will make you an Offer for consideration.



CELL TYPE DESCRIPTION OF CELL TYPE CAT.NO. SPECIES ORIGIN OF CELLS COMMON CELL TYPE GROWTH PROPERTIES NUCLEIC ACID / DELIVERED MOLECULE APPLICATION PRODUCT REFERENCE TYPE BIBLIOGRAPHIC DATA PDF LINK

Pig bone grafts Swine bone unknown plasmid in vivo application Metafectene PRO application note

143B

Human osteosarcoma cell line ATCC CRL-8303 Human bone cell line adherent siRNA RNA-Interference Metafectene SI publication M. Leopizzi., PhD Thesis, 2018, University of Rome Link

143B

Human osteosarcoma cell line ATCC CRL-8303 Human bone cell line adherent siRNA RNA-Interference Metafectene SI publication V. R. Lo Vasco et al., Anticancer Res, Aug 2014; 34: 4069 - 4075

143B

Human osteosarcoma cell line ATCC CRL-8304 Human bone cell line adherent plasmid Metafectene application note

143B

Human osteosarcoma cell line ATCC CRL-8303 Human bone cell line adherent siRNA RNA-Interference Metafectene SI publication V. R. Lo Vasco et al., J. Cell Commun. Signal., 2015, 9:55-62; DOI 10.1007/s12079-015-0265-y

143B

Human osteosarcoma cell line ATCC CRL-8303 Human bone cell line adherent plasmid stable transfection Metafectene PRO publication A. D’Angelo, Dissertation, University of Parma Link

143B

Human osteosarcoma cell line ATCC CRL-8303 Human bone cell line adherent siRNA RNA-Interference Metafectene SI publication V. R. L. Vasco et al., J. Cell Commun. Signal, 2014, 8:219-229, DOI 10.1007/s12079-014-0235-9 Link

143B

Human osteosarcoma cell line ATCC CRL-8303 Human bone cell line adherent plasmid Metafectene PRO application note

BMSC

Rabbit bone marrow stromal cells Rabbit bone primary cell adherent plasmid Metafectene publication F. Geiger et al., J. Funct. Biomater., 2012, 3, 313-326; doi:10.3390/jfb3020313 Link

BMSC

Rabbit bone marrow stromal cells Rabbit bone primary cell adherent plasmid Metafectene publication P. Kasten et al., Cells Tissues Organs, 2012, 196: 523–533, DOI: 10.1159/000337490 Link

CS-1

Human chondrosarcoma cell line Human bone cell line plasmid Metafectene publication P. Orth et al., Mol Biotechnol, Feb 2008; 38(2): 137-44

DC2.4

Mouse dendritic cell line Mouse bone cell line siRNA RNA-Interference Metafectene publication X. You et al., Fish and Shellfish Immunology, 2018, 72: 356-366, doi.org/10.1016/j.fsi.2017.11.014 Link

DC2.4

Mouse dendritic cell line Mouse bone cell line siRNA RNA-Interference Metafectene publication A. S. Timin et al., Nanomedicine: NBM 2018, 14:97-108, doi.org/10.1016/j.nano.2017.09.001 Link

hBMSC

Human bone marrow-derived mesenchymal stem cells Human bone primary cell adherent siRNA RNA-Interference Metafectene PRO publication E. J. Lee et al., Mol. Therapy, 2017, 26(3): 845-859, doi.org/10.1016/j.ymthe.2017.12.015 Link

hBMSC

Human bone marrow-derived mesenchymal stem cells Human bone stem cell adherent siRNA Metafectene PRO publication E. J. Lee, Mol. Therapy, 2018, doi: 10.1016/j.ymthe.2017.12.015

hBMSC

Human bone marrow-derived mesenchymal stem cells Human bone stem cell adherent plasmid Metafectene publication D. Malik et al., PLoSONE, 13(9):e0203614, doi.org/10.1371/journal.pone.0203614 Link

Hs888

Human osteosarcoma cell line Human bone cell line adherent siRNA RNA-Interference Metafectene SI publication V. R. L. Vasco et al., J. Cell Commun. Signal, 2014, 8:219-229, DOI 10.1007/s12079-014-0235-9 Link

Hs888

Human osteosarcoma cell line Human bone cell line adherent siRNA RNA-Interference Metafectene SI publication M. Leopizzi., PhD Thesis, 2018, University of Rome Link

Hs888

Human osteosarcoma cell line Human bone cell line adherent siRNA RNA-Interference Metafectene SI publication V. R. Lo Vasco et al., Anticancer Res, Aug 2014; 34: 4069 - 4075

Hs888

Human osteosarcoma cell line Human bone cell line adherent siRNA RNA-Interference Metafectene SI publication V. R. Lo Vasco et al., J. Cell Commun. Signal., 2015, 9:55-62; DOI 10.1007/s12079-015-0265-y

M2-10B4

Murine bone marrow stroma cells ATCC CRL-1972 Murine bone unknown adherent plasmid Metafectene PRO application note

MC3T3-E1

Mouse osteoblast cell line ATCC CRL-2593 Mouse bone cell line adherent siRNA RNA-Interference Metafectene publication Y.-y. Li et al., FASEB, 2012

MC3T3-E1

Mouse osteoblast cell line ATCC CRL-2593 Mouse bone cell line adherent plasmid Metafectene publication C.-L. Tsai et al., Journal of Biomedical Science, 2014, 21:12, doi:10.1186/1423-0127-21-12 Link

MC3T3-E1

Mouse osteoblast cell line ATCC CRL-2593 Mouse bone cell line adherent siRNA RNA-Interference Metafectene publication C.-L. Tsai et al., Journal of Biomedical Science, 2014, 21:12, doi:10.1186/1423-0127-21-12 Link

MC3T3-E1

Mouse osteoblast cell line ATCC CRL-2593 Mouse bone cell line adherent siRNA RNA-Interference Metafectene publication C.-L. Tsai et al., Bone, 2014, 60 :186-197, doi.org/10.1016/j.bone.2013.12.014

Set Descending Direction

1-25 of 120

Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5